PMAIP1 and cancer: Extensive research has demonstrated Noxa's significance in rheumatic diseases, malignant tumors, and anticancer drug responses, including its involvement in conditions such as rheumatoid arthritis17, colorectal cancer18, lung cancer19, and sensitization to anticancer agents20.